EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED

Active United Kingdom

Activities of head offices

0 employees website.com
Activities of head offices
E

EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED

Activities of head offices

Founded 9 Feb 1904 Active United Kingdom 0 employees website.com
Activities of head offices
Accounts Submitted 24 May 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 3 Jun 2026 Next due 17 Jun 2027 12 months remaining
Net assets £1M £1K 2024 year on year
Total assets £1M £39K 2024 year on year
Total Liabilities £69K £38K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Full company profile for EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED (SC005534), an active company based in United Kingdom. Incorporated 9 Feb 1904. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type audit-exemption-subsidiary
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£1.21M

Decreased by £1.00k (-0%)

Total Liabilities

£69.00k

Decreased by £38.00k (-36%)

Turnover

N/A

Employees

N/A

Debt Ratio

5%

Decreased by 3 (-38%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Ciara Martha LynchDirectorIrishEngland572 Mar 2020Active

Shareholders

Shareholders (1)

Glaxo Group Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Glaxo Group Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GSK PLC united kingdom
GLAXO GROUP LIMITED united kingdom
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Jun 2026Confirmation StatementConfirmation statement made on 3 Jun 2026 with no updates
24 May 2026AccountsAnnual accounts made up to 31 Dec 2025
24 May 2026AccountsAnnual accounts made up to 31 Dec 2025
24 May 2026OtherAudit exemption statement of guarantee by parent company for period ending 31/12/25
24 May 2026OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/25
3 Jun 2026 Confirmation Statement

Confirmation statement made on 3 Jun 2026 with no updates

24 May 2026 Accounts

Annual accounts made up to 31 Dec 2025

24 May 2026 Accounts

Annual accounts made up to 31 Dec 2025

24 May 2026 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/25

24 May 2026 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/25

Recent Activity

Latest Activity

Confirmation statement made on 3 Jun 2026 with no updates

5 days ago on 3 Jun 2026

Annual accounts made up to 31 Dec 2025

2 weeks ago on 24 May 2026

Annual accounts made up to 31 Dec 2025

2 weeks ago on 24 May 2026

Audit exemption statement of guarantee by parent company for period ending 31/12/25

2 weeks ago on 24 May 2026

Notice of agreement to exemption from audit of accounts for period ending 31/12/25

2 weeks ago on 24 May 2026